Filing Details
- Accession Number:
- 0000899243-17-024381
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-17 17:11:52
- Reporting Period:
- 2017-10-13
- Accepted Time:
- 2017-10-17 17:11:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1374690 | Zafgen Inc. | ZFGN | Pharmaceutical Preparations (2834) | 203857670 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1441724 | K Frances Heller | C/O Zafgen, Inc. 175 Portland Street, 4Th Floor Boston MA 02114 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-10-13 | 10,000 | $3.90 | 47,961 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.8645 to $3.92, inclusive. The reporting person undertakes to provide to Zafgen, Inc., any security holder of Zafgen, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
- Total number of shares includes 7,961 shares of Common Stock acquired by the Reporting Person on December 31, 2012 that were not previously reported.
Billionaire Hedge Funds
